189 related articles for article (PubMed ID: 29390266)
41. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
Frank-Raue K; Raue F
Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract][Full Text] [Related]
43. Smoldering medullary thyroid carcinoma liver metastasis 37 years after resection of an organ-confined tumor.
Waters KM; Ali SZ; Erozan YS; Olson MT
Diagn Cytopathol; 2015 Jan; 43(1):45-8. PubMed ID: 24550155
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic Challenges of Medullary Thyroid Carcinoma.
Leimbach RD; Hoang TD; Shakir MKM
Oncology; 2021; 99(7):422-432. PubMed ID: 33878761
[TBL] [Abstract][Full Text] [Related]
45. [Pycnodysostosis: a rare disease with frequent fractures].
Sánchez Lázaro JA; Linares Álvarez L
Semergen; 2014 Apr; 40(3):e47-50. PubMed ID: 23759316
[TBL] [Abstract][Full Text] [Related]
46. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications.
Boschin IM; Torresan F; Toniato A; Zane M; Ide EC; Pennelli G; Rampin L; Colletti PM; Rubello D; Pelizzo MR
Endocrine; 2014 Apr; 45(3):448-53. PubMed ID: 23884895
[TBL] [Abstract][Full Text] [Related]
47. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
[TBL] [Abstract][Full Text] [Related]
48. Not all pycnodysostosis-related mutants of human cathepsin K are inactive - crystal structure and biochemical studies of an active mutant I249T.
Roy S; Das Chakraborty S; Biswas S
FEBS J; 2018 Nov; 285(22):4265-4280. PubMed ID: 30199612
[TBL] [Abstract][Full Text] [Related]
49. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
50. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
[TBL] [Abstract][Full Text] [Related]
51. Whole-exome sequencing identified a novel variant in an Iranian patient affected by pycnodysostosis.
Razmara E; Azimi H; Bitaraf A; Daneshmand MA; Galehdari M; Dokhanchi M; Esmaeilzadeh-Gharehdaghi E; Garshasbi M
Mol Genet Genomic Med; 2020 Mar; 8(3):e1118. PubMed ID: 31944631
[TBL] [Abstract][Full Text] [Related]
52. Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.
Jayakody S; Reagh J; Bullock M; Aniss A; Clifton-Bligh R; Learoyd D; Robinson B; Delbridge L; Sidhu S; Gill AJ; Sywak M
World J Surg; 2018 May; 42(5):1432-1439. PubMed ID: 29484475
[TBL] [Abstract][Full Text] [Related]
53. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
[TBL] [Abstract][Full Text] [Related]
54. Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto-oncogene mutations.
Boybeyi-Türer Ö; Vurallı D; Karnak İ; Gönç N; Yalçın EŞ; Orhan D; Kandemir N; Tanyel FC
Turk J Pediatr; 2016; 58(4):436-441. PubMed ID: 28276221
[TBL] [Abstract][Full Text] [Related]
55. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
56. Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?
Bümming P; Ahlman H; Nilsson B; Nilsson O; Wängberg B; Jansson S
Langenbecks Arch Surg; 2008 Sep; 393(5):699-703. PubMed ID: 18626656
[TBL] [Abstract][Full Text] [Related]
57. Hashimoto's Thyroiditis and Medullary Carcinoma of Thyroid.
Dasgupta S; Chakrabarti S; Mandal PK; Das S
JNMA J Nepal Med Assoc; 2014; 52(194):831-3. PubMed ID: 26905714
[TBL] [Abstract][Full Text] [Related]
58. Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age.
Spinelli C; Strambi S; Rossi L; Elisei R; Massimino M
Curr Pediatr Rev; 2016; 12(4):280-285. PubMed ID: 27834132
[TBL] [Abstract][Full Text] [Related]
59. The role of cathepsin K in oral and maxillofacial disorders.
Wen X; Yi LZ; Liu F; Wei JH; Xue Y
Oral Dis; 2016 Mar; 22(2):109-15. PubMed ID: 26458004
[TBL] [Abstract][Full Text] [Related]
60. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
